Le Lézard
Classified in: Health
Subjects: RCL, PSF

Food Recall Warning (Allergen) - CLIF BUILDER'S brand Mint Chocolate Protein Bars recalled due to undeclared peanuts, tree nuts and coconut


Product photos are available at http://bit.ly/2sIxdr0

OTTAWA, July 5, 2017 /CNW/ - Industry is recalling CLIF BUILDER'S brand Mint Chocolate Protein Bars from the marketplace because they may contain peanuts, tree nuts and coconut which are not declared on the label. People with an allergy to peanuts, tree nuts or coconut should not consume the recalled products described below.

The following products have been sold nationally as well as through Internet sales.

Recalled products

 

Brand

Product

Size

UPC

Codes

CLIF BUILDER'S

Chocolate Mint Protein Bar

68 g

7 22252 60644 0

From 2016JN19M6 to 2018MR08M6

CLIF BUILDER'S

Chocolate Mint Protein Bar

6 x 68 g

7 22252 60444 6

From 2016JN19M6 to 2018MR08M6

CLIF BUILDER'S

Chocolate Mint Protein Bar

12 x 68 g

7 22252 61644 9

From 2016JN19M6 to 2018MR08M6

CLIF BUILDER'S

Protein Bars Variety Pack

18 x 68 g

7 22252 61633 3

From 2016JN18M55210 to 2018FE147095

 

What you should do

Check to see if you have recalled products in your home. Recalled products should be thrown out or returned to the store where they were purchased.

If you have an allergy to peanuts, tree nuts or coconut do not consume the recalled products as they may cause a serious or life-threatening reaction.

Background

This recall was triggered by the company. The Canadian Food Inspection Agency (CFIA) is conducting a food safety investigation, which may lead to the recall of other products. If other high-risk products are recalled, the CFIA will notify the public through updated Food Recall Warnings.

The CFIA is verifying that industry is removing recalled product from the marketplace.

Reactions

There have been reported reactions associated with the consumption of these products.

More information

 

SOURCE Canadian Food Inspection Agency (CFIA)


These press releases may also interest you

at 14:20
The global gastroesophageal reflux disease (GERD) market  size is estimated to grow by USD 879.8 million from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  3.2%  during the forecast period.  Rising geriatric...

at 12:48
Pendopharm, a division of Pharmascience Inc., announced today that it has signed an exclusive distribution agreement with Ascendis Pharma A/S ("Ascendis"), a global biopharmaceutical company headquartered in Copenhagen, Denmark. Under the terms of...

at 12:36
Imperial Tobacco Canada Limited ("ITCAN") has officially submitted its feedback to Health Canada regarding the proposed Ministerial Order on nicotine replacement therapy products (NRTs). ITCAN strongly believes that NRTs, especially innovative...

at 12:20
The "Regenerative Medicine Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Regenerative Medicine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented...

at 12:10
The "Diagnostic Imaging Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Diagnostic Imaging Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to...

at 12:05
King Faisal Specialist Hospital & Research Centre (KFSH&RC) has achieved a significant milestone in its Robotic Cardiac Surgery Program, which was initiated in February 2019. Within its first year, the program performed 105 cardiac procedures. As of...



News published on and distributed by: